These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9216670)

  • 1. The effects of cantharidin analogues on xanthine oxidase.
    Tsauer W; Lin JG; Lin PY; Hsu FL; Chiang HC
    Anticancer Res; 1997; 17(3C):2095-8. PubMed ID: 9216670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
    Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cantharidin-based small molecules as potential therapeutic agents.
    Puerto Galvis CE; Vargas Méndez LY; Kouznetsov VV
    Chem Biol Drug Des; 2013 Nov; 82(5):477-99. PubMed ID: 23809227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
    Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
    J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
    Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
    ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
    McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical uses of mylabris in ancient China and recent studies.
    Wang GS
    J Ethnopharmacol; 1989 Sep; 26(2):147-62. PubMed ID: 2689797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
    Yeh CB; Su CJ; Hwang JM; Chou MC
    Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel xanthone derivatives as xanthine oxidase inhibitors.
    Hu L; Hu H; Wu W; Chai X; Luo J; Wu Q
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4013-5. PubMed ID: 21620698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge.
    Thaqi A; Scott JL; Gilbert J; Sakoff JA; McCluskey A
    Eur J Med Chem; 2010 May; 45(5):1717-23. PubMed ID: 20153915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of xanthine oxidase by benzothiazinone analogues.
    Sheu SY; Lin CY; Wu JD; Chiang HC
    Anticancer Res; 1999; 19(1A):119-23. PubMed ID: 10226532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of plant growth regulators on xanthine oxidase.
    Sheu SY; Chiang HC
    Anticancer Res; 1996; 16(1):311-5. PubMed ID: 8615627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors.
    Hsieh JF; Wu SH; Yang YL; Choong KF; Chen ST
    Bioorg Med Chem; 2007 May; 15(10):3450-6. PubMed ID: 17379526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of xanthine oxidase by purpurogallin and silymarin group.
    Sheu SY; Lai CH; Chiang HC
    Anticancer Res; 1998; 18(1A):263-7. PubMed ID: 9568088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of xanthine oxidase by hydroxylated anthraquinones and related compounds.
    Sheu SY; Chiang HC
    Anticancer Res; 1997; 17(5A):3293-7. PubMed ID: 9413162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors.
    Gupta S; Rodrigues LM; Esteves AP; Oliveira-Campos AM; Nascimento MS; Nazareth N; Cidade H; Neves MP; Fernandes E; Pinto M; Cerqueira NM; Brás N
    Eur J Med Chem; 2008 Apr; 43(4):771-80. PubMed ID: 17692432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential in vitro inhibition studies of some cerium vanadate derivatives on xanthine oxidase.
    Kaya MO; Kaya Y; Çelik G; Kurtuluş F; Arslan O; Güler ÖÖ
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):286-9. PubMed ID: 24964345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of xanthine oxidase by synthetic cytokinin analogues.
    Sheu SY; Lin YC; Chiang HC
    Anticancer Res; 1997; 17(2A):1043-9. PubMed ID: 9137447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of new imidazole, pyrimidine, and purine derivatives and analogs as inhibitors of xanthine oxidase.
    Biagi G; Costantini A; Costantino L; Giorgi I; Livi O; Pecorari P; Rinaldi M; Scartoni V
    J Med Chem; 1996 Jun; 39(13):2529-35. PubMed ID: 8691450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the study of Cantharidin and its derivatives].
    Liu J; Gao J; Liu X
    Zhong Yao Cai; 2003 Jun; 26(6):453-5. PubMed ID: 14666949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.